1. Home
  2. BNR vs NDLS Comparison

BNR vs NDLS Comparison

Compare BNR & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • NDLS
  • Stock Information
  • Founded
  • BNR 2014
  • NDLS 1995
  • Country
  • BNR China
  • NDLS United States
  • Employees
  • BNR N/A
  • NDLS N/A
  • Industry
  • BNR Medical Specialities
  • NDLS Restaurants
  • Sector
  • BNR Health Care
  • NDLS Consumer Discretionary
  • Exchange
  • BNR Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • BNR 29.1M
  • NDLS 32.9M
  • IPO Year
  • BNR 2020
  • NDLS 2013
  • Fundamental
  • Price
  • BNR $4.22
  • NDLS $0.90
  • Analyst Decision
  • BNR
  • NDLS Strong Buy
  • Analyst Count
  • BNR 0
  • NDLS 2
  • Target Price
  • BNR N/A
  • NDLS $3.00
  • AVG Volume (30 Days)
  • BNR 29.7K
  • NDLS 223.1K
  • Earning Date
  • BNR 08-21-2025
  • NDLS 08-06-2025
  • Dividend Yield
  • BNR N/A
  • NDLS N/A
  • EPS Growth
  • BNR N/A
  • NDLS N/A
  • EPS
  • BNR N/A
  • NDLS N/A
  • Revenue
  • BNR $72,112,038.00
  • NDLS $495,670,000.00
  • Revenue This Year
  • BNR $136.32
  • NDLS $5.37
  • Revenue Next Year
  • BNR N/A
  • NDLS $0.68
  • P/E Ratio
  • BNR N/A
  • NDLS N/A
  • Revenue Growth
  • BNR 0.53
  • NDLS N/A
  • 52 Week Low
  • BNR $2.18
  • NDLS $0.55
  • 52 Week High
  • BNR $7.90
  • NDLS $1.83
  • Technical
  • Relative Strength Index (RSI)
  • BNR 63.77
  • NDLS 61.53
  • Support Level
  • BNR $3.06
  • NDLS $0.66
  • Resistance Level
  • BNR $3.50
  • NDLS $0.82
  • Average True Range (ATR)
  • BNR 0.21
  • NDLS 0.08
  • MACD
  • BNR 0.05
  • NDLS 0.02
  • Stochastic Oscillator
  • BNR 95.65
  • NDLS 93.68

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: